Efficacy and Safety of SPARC0921 in Subjects With Spasticity
Public ClinicalTrials.gov record NCT01457352. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to assess whether SPARC0921 demonstrate efficacy and safety in the treatment of spasticity.
Study identification
- NCT ID
- NCT01457352
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 392 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 14, 2012 (Actual)
- Primary completion
- Aug 25, 2017 (Actual)
- Completion
- Aug 25, 2017 (Actual)
- Last update posted
- Jun 18, 2019
2012 – 2017
United States locations
- U.S. sites
- 56
- U.S. states
- 26
- U.S. cities
- 53
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| SPARC site 6 | Gilbert | Arizona | — | — |
| SPARC Site 40 | Phoenix | Arizona | — | — |
| SPARC Site 36 | Costa Mesa | California | — | — |
| SPARC Site 20 | Newport Beach | California | — | — |
| SPARC Site 38 | Basalt | Colorado | — | — |
| SPARC Site 21 | Denver | Colorado | — | — |
| SPARC Site 9 | Derby | Connecticut | — | — |
| SPARC Site 57 | Hartford | Connecticut | — | — |
| SPARC Site 10 | New London | Connecticut | — | — |
| SPARC Site 60 | Washington D.C. | District of Columbia | — | — |
| SPARC Site 15 | Bradenton | Florida | — | — |
| SPARC Site 54 | Jacksonville | Florida | — | — |
| SPARC Site 41 | Maitland | Florida | — | — |
| SPARC Site 70 | Miami | Florida | — | — |
| SPARC Site 8 | Ormond Beach | Florida | — | — |
| SPARC Site 17 | Port Charlotte | Florida | — | — |
| SPARC Site 19 | Sarasota | Florida | — | — |
| SPARC Site 31 | Sunrise | Florida | — | — |
| SPARC Site 39 | Tampa | Florida | — | — |
| SPARC Site 65 | Tampa | Florida | — | — |
| SPARC Site 51 | Lenexa | Kansas | — | — |
| SPARC Site 30 | Overland Park | Kansas | — | — |
| SPARC Site 50 | Louisville | Kentucky | — | — |
| SPARC Site 42 | Alexandria | Louisiana | — | — |
| SPARC Site 27 | Baton Rouge | Louisiana | — | — |
| SPARC Site 73 | New Orleans | Louisiana | — | — |
| SPARC Site 35 | Foxborough | Massachusetts | — | — |
| SPARC Site 23 | Springfield | Massachusetts | — | — |
| SPARC Site 32 | Clinton Township | Michigan | — | — |
| SPARC Site 64 | Detroit | Michigan | — | — |
| SPARC Site 25 | Golden Valley | Minnesota | — | — |
| SPARC Site 5 | Henderson | Nevada | — | — |
| SPARC site 34 | Flemington | New Jersey | — | — |
| SPARC Site 55 | Stratford | New Jersey | — | — |
| SPARC Site 22 | Albuquerque | New Mexico | — | — |
| SPARC Site 49 | Rochester | New York | — | — |
| SPARC Site 45 | Charlotte | North Carolina | — | — |
| SPARC Site 4 | Charlotte | North Carolina | — | — |
| SPARC Site 24 | Greensboro | North Carolina | — | — |
| SPARC Site 2 | Winston-Salem | North Carolina | — | — |
| SPARC Site 75 | Winston-Salem | North Carolina | — | — |
| SPARC Site 16 | Akron | Ohio | — | — |
| SPARC Site 33 | Centerville | Ohio | — | — |
| SPARC Site 56 | Columbus | Ohio | — | — |
| SPARC Site 12 | Eugene | Oregon | — | — |
| SPARC Site 44 | Springfield | Oregon | — | — |
| SPARC Site 68 | Abington | Pennsylvania | — | — |
| SPARC Site 29 | Old Point Station | South Carolina | — | — |
| SPARC Site 7 | Austin | Texas | — | — |
| SPARC Site 71 | Dallas | Texas | — | — |
| SPARC Site 43 | Houston | Texas | — | — |
| SPARC Site 13 | Salt Lake City | Utah | — | — |
| SPARC Site 26 | Tacoma | Washington | — | — |
| SPARC Site 74 | Huntington | West Virginia | — | — |
| SPARC Site 69 | Milwaukee | Wisconsin | — | — |
| SPARC Site 67 | Waukesha | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 17 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01457352, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 18, 2019 · Synced Oct 31, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01457352 live on ClinicalTrials.gov.